<?xml version="1.0" encoding="UTF-8"?>
<p>As already discussed in the previous sections, BACE-1 represents another key enzyme targeted in AD and the importance and effects of dual ChE/BACE-1 inhibitors have been reported (
 <xref ref-type="sec" rid="sec2.1">Section 2.1</xref>). In the search for MTDLs, other interesting combinations may arise from the exploration of novel BACE-1 inhibitors endowed with neuroprotective and anti-inflammatory effects.
</p>
